11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cyclodextrins (CDs) have beneficial characteristics for drug delivery, including hydrophobic interior surfaces. Nanocarriers with β-CD ligands have been prepared with simple surface modifications as drug delivery vehicles. In this study, we synthesized β-CD derivatives on an Ag-embedded silica nanoparticle (NP) (SiO 2@Ag NP) structure to load and release doxorubicin (DOX). Cysteinyl- β-CD and ethylenediamine- β-CD (EDA- β-CD) were immobilized on the surface of SiO 2@Ag NPs, as confirmed by transmission electron microscopy (TEM), ultraviolet-visible (UV-Vis) spectrophotometry, and Fourier transform infrared (FTIR) spectroscopy. DOX was introduced into the β-CD on the SiO 2@Ag NPs and then successfully released. Neither cysteinyl- β-CD and EDA- β-CD showed cytotoxicity, while DOX-loaded cysteinyl- β-CD and EDA- β-CD showed a significant decrease in cell viability in cancer cells. The SiO 2@Ag NPs with β-CD provide a strategy for designing a nanocarrier that can deliver a drug with controlled release from modified chemical types.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: not found
          • Article: not found

          Cyclodextrins and their uses: a review

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications.

            This review describes the synthesis, properties, and, in particular, biomedical and pharmaceutical applications of an upcoming class of polymeric networks and assemblies based on cyclodextrins (CDs). CDs are cyclic oligosaccharides composed of alpha-1,4-coupled d-glucose units, which contain a hydrophobic internal cavity that can act as a host for various, generally lipophilic, guest molecules. Because of this unique physicochemical property, commonly referred to as inclusion complex formation, CDs have often been used to design polymeric materials, such as hydrogels and nanoparticles. Polymeric systems based on CDs exhibit unique characteristics in terms of mechanical properties, stimuli-responsiveness, and drug release characteristics. In this contribution, first, an outline is given of covalently cross-linked polymeric networks in which CD moieties were structurally incorporated to modulate the network strength as well as the complexation and release of low molecular weight drugs. Second, physically assembled polymeric systems are discussed, of which the formation is accomplished by inclusion complexes between polymer-conjugated CDs and various guest molecule-derivatized polymers. Due to their physical nature, these polymeric systems are sensitive to external stimuli, such as temperature changes, shear forces and the presence of competing CD-binding molecules, which can be exploited to use these systems as injectable, in situ gelling devices. In recent years, many interesting CD-containing polymeric systems have been described in literature. These systems have to be optimized and extensively evaluated in preclinical studies concerning their safety and efficacy, making future clinical applications of these materials in the biomedical and pharmaceutical field feasible.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Synthesis and surface functionalization of silica nanoparticles for nanomedicine.

              There are a wide variety of silica nanoformulations being investigated for biomedical applications. Silica nanoparticles can be produced using a wide variety of synthetic techniques with precise control over their physical and chemical characteristics. Inorganic nanoformulations are often criticized or neglected for their poor tolerance; however, extensive studies into silica nanoparticle biodistributions and toxicology have shown that silica nanoparticles may be well tolerated, and in some case are excreted or are biodegradable. Robust synthetic techniques have allowed silica nanoparticles to be developed for applications such as biomedical imaging contrast agents, ablative therapy sensitizers, and drug delivery vehicles. This review explores the synthetic techniques used to create and modify an assortment of silica nanoformulations, as well as several of the diagnostic and therapeutic applications.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                14 January 2019
                January 2019
                : 20
                : 2
                : 315
                Affiliations
                [1 ]Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea; ejkang@ 123456konkuk.ac.kr (E.J.K.); undine1213@ 123456naver.com (Y.M.B.); greenice@ 123456konkuk.ac.kr (E.H.); shlee.ucb@ 123456gmail.com (S.H.L.); phamricky@ 123456gmail.com (X.-H.P.); kimde@ 123456konkuk.ac.kr (D.-E.K.)
                [2 ]Bio-Health Convergence Institute, Korea Testing Certification, Gunpo 15809, Korea; pourlady@ 123456ktc.re.kr
                Author notes
                [* ]Correspondence: bjun@ 123456konkuk.ac.kr ; Tel.: +82-450-0521
                Author information
                https://orcid.org/0000-0002-4927-7102
                https://orcid.org/0000-0001-6556-7946
                Article
                ijms-20-00315
                10.3390/ijms20020315
                6359520
                30646562
                cde0f952-0ea3-4de1-9bf8-bda362ce86bc
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 18 December 2018
                : 12 January 2019
                Categories
                Article

                Molecular biology
                cyclodextrin,doxorubicin (dox),drug delivery
                Molecular biology
                cyclodextrin, doxorubicin (dox), drug delivery

                Comments

                Comment on this article